HomeTagsHigh Bleeding Risk Stent Patients

High Bleeding Risk Stent Patients

Medtronic Onyx ONE Clear Study of One-Month Dual-Antiplatelet Therapy in High Bleeding Risk Stent Patients Beats Performance Goal

Medtronic Onyx ONE Clear Study met its primary endpoint of cardiac death or myocardial infarction by beating a performance goal derived from contemporary one-month DAPT trials at one-year post-procedure.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version